CD8A and ovarian carcinoma: Comparison of the CD8+ T-cell infiltration between HHLA2-positive (Fig. 4a, b) and -negative (Fig. 4c, d) patients illustrated that the CD8+ T-cell density was increased in patients with HHLA2-positive ovarian cancer.